Evidence map›Paper›PMID 32206187›Full record

ArticleOncotarget2020

DNA methylation of MMPs and TIMPs in atherothrombosis process in carotid plaques and blood tissues.

Cristina Gallego-Fabrega, Natalia Cullell, Carolina Soriano-Tárraga, Caty Carrera, Nuria P Torres-Aguila, Elena Muiño, Jara Cárcel-Márquez, Manuel Castro de Moura, Alba Fernández-Sanlés, Manel Esteller and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Journal of inflammation research · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Cristina Gallego-FabregaNeurology, Hospital Universitari Mútua de Terrassa/Fundacio Docència i Recerca MutuaTerrassa, Terrassa, Spain.
Natalia CullellNeurology, Hospital Universitari Mútua de Terrassa/Fundacio Docència i Recerca MutuaTerrassa, Terrassa, Spain.
Carolina Soriano-TárragaDepartment of Neurology, Hospital del Mar, Neurovascular Research Group, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Barcelona, Spain.
Caty CarreraStroke Pharmacogenomics and Genetics, Sant Pau Research Institute, Barcelona, Spain.
Nuria P Torres-AguilaStroke Pharmacogenomics and Genetics, Sant Pau Research Institute, Barcelona, Spain.
Elena MuiñoStroke Pharmacogenomics and Genetics, Sant Pau Research Institute, Barcelona, Spain.
Jara Cárcel-MárquezStroke Pharmacogenomics and Genetics, Sant Pau Research Institute, Barcelona, Spain.
Manuel Castro de MouraJosep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.
Alba Fernández-SanlésCardiovascular Epidemiology and Genetics Research Group, Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, Barcelona, Spain.
Manel EstellerJosep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.
Roberto ElosuaCardiovascular Epidemiology and Genetics Research Group, Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, Barcelona, Spain.
Jordi Jiménez-CondeDepartment of Neurology, Hospital del Mar, Neurovascular Research Group, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Barcelona, Spain.
Jaume RoquerDepartment of Neurology, Hospital del Mar, Neurovascular Research Group, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Barcelona, Spain.
Joan MontanerNeurovascular Research Laboratory, Vall d'Hebron Institute of Research, Universitat Autònoma de Barcelona, Barcelona, Spain.
Jerzy KrupinskiNeurology, Hospital Universitari Mútua de Terrassa/Fundacio Docència i Recerca MutuaTerrassa, Terrassa, Spain.
Israel Fernandez-CadenasStroke Pharmacogenomics and Genetics, Sant Pau Research Institute, Barcelona, Spain.
Pompeu Fabra University · ESUniversitat Autònoma de Barcelona · ESUniversitat de Barcelona · ESJosep Carreras Leukaemia Research Institute · ESManchester Metropolitan University · GBMútua Terrassa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposePolymorphisms and serum levels of Matrix Metalloproteinases (MMP) and Tissue Inhibitor of Metalloproteinases (TIMP) have been studied with regard to atheromatous plaques and ischemic stroke, while no studies of DNA methylation (DNAm) patterns of

methodsWe profiled the DNAm status of stable and ulcerated atherosclerotic plaques obtained as pair sets from three patients who underwent carotid endarterectomy surgery. We selected 415 CpG sites, mapping into

resultsThree CpG sites were statistically significantly associated with unstable plaque portions; cg02969624,

conclusionsThe results suggest different DNAm status of MMP24 between stable and unstable atherothrombotic carotid plaques, and between atherothrombotic stroke and controls in blood samples.

Indexed as

atherosclerotic plaqueDNA methylationepigeneticsmatrix metalloproteinases

Identifiers

PMID32206187
PMCPMC7075467
OpenAlexW3011655824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.